X2S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 2.309 EUR -3.35% Market Closed

Market Cap: €7.2B

S	Sinopharm Group Co Ltd XBER:X2S	CN
	Dabur India Ltd BSE:500096	IN
C	Coca-Cola Co XMUN:CCC3	US
	Realty Income Corp BMV:O	US
A	Aeroports de Paris SA XBER:W7L	FR
	Rush Enterprises Inc F:RUN	US
	Palo Alto Networks Inc BMV:PANW	US
	Fomento de Construcciones y Contratas SA OTC:FMOCY	ES
	Novus Holdings Ltd F:N09	ZA
L	LyondellBasell Industries NV LSE:0EDD	UK

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

9% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

3% > 3%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.